Weiping Ren Selected Research

Erythromycin (Erycette)

10/2016	The Chondroprotective Role of Erythromycin in a Murine Joint Destruction Model.
8/2011	Emerging ideas: can erythromycin reduce the risk of aseptic loosening?
6/2011	Poly(amidoamine) dendrimer-erythromycin conjugates for drug delivery to macrophages involved in periprosthetic inflammation.
1/2011	Cyclodextrin-erythromycin complexes as a drug delivery device for orthopedic application.
12/2010	Efficacy of periprosthetic erythromycin delivery for wear debris-induced inflammation and osteolysis.
7/2009	Inhibitory effects of erythromycin on wear debris-induced VEGF/Flt-1 gene production and osteolysis.
2/2006	Erythromycin inhibits wear debris-induced inflammatory osteolysis in a murine model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weiping Ren Research Topics

Disease

15	Inflammation (Inflammations) 10/2016 - 09/2002
10	Infections 10/2022 - 08/2012
10	Osteolysis 08/2011 - 02/2006
6	Bone Resorption 07/2009 - 09/2002
2	Osteomyelitis 12/2015 - 07/2013
2	Communicable Diseases (Infectious Diseases) 06/2011 - 01/2011
1	Staphylococcal Infections 07/2017
1	Synovitis 10/2016
1	Melanoma (Melanoma, Malignant) 09/2013

Drug/Important Bio-Agent (IBA)

11	ultra-high molecular weight polyethylene (UHMWPE)IBA 08/2014 - 09/2002
7	Erythromycin (Erycette)FDA LinkGeneric 10/2016 - 02/2006
6	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 01/2011
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010 - 11/2003
3	CytokinesIBA 07/2019 - 03/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011 - 01/2007
3	Proteins (Proteins, Gene)FDA Link 01/2011 - 02/2006
3	Interleukin-1beta (Interleukin 1 beta)IBA 03/2010 - 01/2007
3	CollagenIBA 06/2008 - 02/2006
2	Polymethyl Methacrylate (Sol)IBA 11/2021 - 12/2015
2	TitaniumIBA 07/2017 - 08/2011
2	Polyethylene (Polythene)IBA 08/2011 - 09/2002
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2011 - 07/2009
2	Biological ProductsIBA 03/2010 - 04/2009
1	Vancomycin FDA LinkGeneric 01/2022
1	Polyvinyl AlcoholIBA 01/2022
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2022
1	dihydrate dibasic calcium phosphate (brushite)IBA 11/2021
1	C-Reactive ProteinIBA 07/2019
1	Doxycycline (Periostat)FDA LinkGeneric 07/2017
1	Iodoacetic AcidIBA 10/2016
1	Bone SubstitutesIBA 12/2015
1	hylanIBA 10/2014
1	Chemokine ReceptorsIBA 08/2014
1	ChemokinesIBA 08/2014
1	poly(vinyl alcohol)-hylauronic acidIBA 09/2013
1	GelatinIBA 07/2013
1	genipinIBA 07/2013
1	beta-tricalcium phosphateIBA 07/2013
1	Gentamicins (Gentamicin)FDA LinkGeneric 07/2013
1	PolymersIBA 08/2012
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 08/2012
1	ApatitesIBA 08/2011
1	Durapatite (Hydroxylapatite)IBA 08/2011
1	Poly(amidoamine)IBA 06/2011
1	Pharmaceutical PreparationsIBA 06/2011
1	Dendrimers (Dendrons)IBA 06/2011
1	CyclodextrinsIBA 01/2011
1	Semaxinib (SU5416)IBA 01/2011
1	Neutralizing AntibodiesIBA 01/2011
1	Chaperonin 60IBA 03/2010
1	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2010
1	Interleukin-1 (Interleukin 1)IBA 07/2009
1	Liposomes (Liposome)IBA 06/2008
1	Clodronic Acid (Clodronate)IBA 06/2008
1	LigandsIBA 08/2006
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 08/2006
1	Messenger RNA (mRNA)IBA 02/2006
1	NF-kappa B (NF-kB)IBA 01/2004
1	Tartrate-Resistant Acid PhosphataseIBA 09/2002
1	Conditioned Culture MediaIBA 09/2002
1	MethacrylatesIBA 09/2002
1	CalciumIBA 09/2002

Therapy/Procedure

3	Prostheses and Implants (Prosthesis) 10/2022 - 11/2003
2	Arthroplasty 01/2022 - 08/2011
2	Reoperation 08/2011 - 04/2009
1	Sutures (Suture) 01/2019
1	Injections 10/2014
1	Replacement Arthroplasty 09/2013
1	Transjugular Intrahepatic Portasystemic Shunt 09/2013
1	Orthopedic Procedures 07/2013